The antidepressant-like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test

Behavioural Pharmacology

Volumn 14, Issue 1, 2003, Pages 87-95

  Varty, Geoffrey B ^a   Cohen Williams, M E ^a   Hunter, J C ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Antidepressant drugs; Depression; Gerbil; Neurokinin NK1 receptor antagonists; Substance P; Tail suspension test

Indexed keywords

2 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 4 (3 OXO 1,2,4 TRIAZOL 5 YLMETHYL) 3 PHENYLMORPHOLINE; 3 (2 METHOXY 5 TRIFLUOROMETHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; 3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; 3 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 2 PHENYLPIPERIDINE; AMITRIPTYLINE; AMPHETAMINE; APREPITANT; ATROPINE; BUSPIRONE; CHLORDIAZEPOXIDE; CITALOPRAM; DESIPRAMINE; DIAZEPAM; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; N METHYL BETA CARBOLINE 3 CARBOXAMIDE; NEFAZODONE; PAROXETINE; SERTRALINE; TACHYKININ RECEPTOR ANTAGONIST; VENLAFAXINE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE CALCULATION; DRUG EFFECT; DRUG MECHANISM; FEMALE; GERBIL; HYPERACTIVITY; IMMOBILIZATION; LABORATORY DIAGNOSIS; LOCOMOTION; NONHUMAN; TAIL; TIME; VALIDATION PROCESS;

EID: 0037331104     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200302000-00009     Document Type: Article

References (30)

1. Ballard TM, Sanger S, Higgins GA (2001). Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin NK(1) receptor antagonist. Eur J Pharmacol 412:255-264.
2. Beresford IJ, Birch PJ, Hagan RM, Ireland SJ (1991). Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345. Br J Pharmacol 104:292-293.
3. Bristow LJ, Young L (1994). Chromodacryorrhea and repetitive hind paw tapping: models of peripheral and central tachykinin NK1 receptor activation in gerbils. Eur J Pharmacol 253:245-252.
4. Cheeta S, Tucci S, Sandhu J, Williams AR, Rupniak NM, File SE (2001). Anxiolytic actions of the substance P (NK1) receptor antagonist L-760735 and the 5-HT1A agonist 8-OH-DPAT in the social interaction test in gerbils. Brain Res 915:170-175.
5. Chermat R, Thierry B, Mico JA, Steru L, Simon P (1986). Adaptation of the tail suspension test to the rat. J Pharmacol 17:348-350.
6. Cutler MG, Piper DC (1990). Chronic administration of the 5-HT3 receptor antagonist BRL 43694; effects on reflex epilepsy and social behaviour of the Mongolian gerbil. Psychopharmacology 101:244-249.
7. Dalvi A, Hogg S (2001). Preliminary validation of the gerbil tail suspension test as a screening test for antidepressant compounds: Comparison with the mouse tail suspension test. J Psychopharmacol 15:A24.
8. David DJ, Nic Dhonnchadha BA, Jolliet P, Hascoet M, Bourin M (2001). Are there gender differences in the temperature profile of mice after acute antidepressant administration and exposure to two animal models of depression? Behav Brain Res 119:203-211.
9. File SE, Cheeta S, Akanezi C (2001). Diazepam and nicotine increase social interaction in gerbils: a test for anxiolytic action. Brain Res 888:311-313.
10. Gitter BD, Waters DC, Bruns RF, Mason NR, Nixon JA, Howbert JJ (1991). Species differences in affinities of non-peptide antagonists for substance P receptors. Eur J Pharmacol 197:237-238.
11. Graham EA, Turpin MP, Stubbs CM (1993). Characterisation of the tachykinin-induced hindlimb thumping response in gerbils. Neuropeptides 4:228.
12. Kramer MS, Curler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, et al. (1998). Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281:1640-1645.
13. McLean S, Ganong A, Seymour PA, Snider RM, Desai MC, Rosen T, et al. (1993). Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor. J Pharmacol Exp Ther 267:472-479.
14. McLean S, Ganong A, Seymour PA, Bryce DK, Crawford RT, Morrone J, et al. (1996). Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptor. J Pharmacol Exp Ther 277:900-908.
15. O'Neill MF, Fernandez AG, Palacios JM (1996). GR 127935 blocks the locomotor and antidepressant-like effects of RU 24969 and the action of antidepressants in the mouse tail suspension test. Pharmacol Biochem Behav 53:535-539.
16. Papp M, Vassout A, Gentsch C (2000). The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats. Behav Brain Res 115:19-23.
17. Perrault G, Morel E, Zivkovic B, Sanger DJ (1992). Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice. Pharmacol Biochem Behav 42:45-47.
18. Pradier L, Habert-Ortoli E, Emile L, Le Guern J, Loquet I, Bock MD, et al. (1995). Molecular determinants of the species selectivity of neurokinin type 1 receptor antagonists. Mol Pharmacol 47:314-321.
19. Rupniak NM, Williams AR (1994). Differential inhibition of foot tapping and chromodacryorrhoea in gerbils by CNS penetrant and non-penetrant tachykinin NK1 receptor antagonists. Eur J Pharmacol 265:179-183.
20. Rupniak NM, Tattersall FD, Williams AR, Rycroft W, Carlson FJ, Cascieri MA, et al. (1997). In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists. Eur J Pharmacol 326:201-209.
21. Rupniak NMJ, Carlson EJ, Webb JK, Harrison T, Porsolt RD, Roux S, et al. (2001). Comparison of the phenotype of NK1R -/- mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytic drugs. Behav Pharmacol12:497-508.
22. Saria A (1999). The tachykinin NK1 receptor in the brain: pharmacology and putative functions. Eur J Pharmacol 375:51-60.
23. Steru L, Chermat R, Thierry B, Simon P (1985). The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367-370.
24. Steru L, Chermat R, Thierry B, Mico JA, Lenegre A, Steru M, et al. (1987). The automated Tail Suspension Test: a computerized device which differentiates psychotropic drugs. Prog Neuropsychopharmacol Biol Psychiatry 11:659-671.
25. Tatarczynska E, Klodzinska A, Chojnacka-Wojcik E, Palucha A, Gasparini F, Kuhn R, Pilc A (2001). Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br J Pharmacol 132:1423-1430.
26. Teste JF, Pelsy-Johann I, Decelle T, Boulu RG (1993). Anti-immobility activity of different antidepressant drugs using the tail suspension test in normal or reserpinized mice. Fundam Clin Pharmacol 7:219-226.
27. Thierry B, Steru L, Simon P, Porsolt RD (1986). The tail suspension test: ethical considerations. Psychopharmacology 90:284-285.
28. Varty GB, Morgan CA, Cohen-Williams ME, Coffin VL, Carey GJ (2002a). The gerbil elevated plus-maze I: Behavioral characterization and pharmacological validation. Neuropsychopharmacology 27:357-370.
29. Varty GB, Cohen-Williams ME, Morgan CA, Pylak U, Duffy RA, Lachowicz JE, et al. (2002b). The gerbil elevated plus-maze II: Anxiolytic-like effects of selective neurokinin NK1 receptor antagonists. Neuropsychopharmacology 27:371-379.
30. Wong EH, Sonders MS, Amara SG, Tinholt PM, Piercey MF, Hoffmann WP, et al. (2000). Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol Psychiatry 47:818-829.